ZynexのIPO年
ZynexのIPO年は何ですか。
Zynex, Inc.のIPO年は2004です。
IPO年の定義は何ですか。
新規公開株 (IPO)は、企業の株式を通常は機関投資家に販売し、順番に証券取引所で一般市民に販売する株式公開の一種です。
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
XETRAのセクタHealth CareにおけるIPO年の企業と比べるZynex
Zynexは何をしますか。
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Zynexと類似のipo年
- Agricultural Land TrustのIPO年は2003です。
- American Equity Investment Life CoのIPO年は2003です。
- Craven House Capital PlcのIPO年は2003です。
- Stone Resources AustraliaのIPO年は2003です。
- Tri-Star Resources PlcのIPO年は2003です。
- Zhejiang RuiYuan Intelligent Control TechnologyのIPO年は2003です。
- ZynexのIPO年は2004です。
- CF Industries IncのIPO年は2005です。
- ToshibaのIPO年は2005です。
- Bankfinancial CorpのIPO年は2005です。
- Blancco Technology PlcのIPO年は2005です。
- Rich GoldmanのIPO年は2005です。
- Olmix Societe AnonymeのIPO年は2005です。